|
 |
ThyrogenThis page contains recent news articles, when available, and an overview of Thyrogen but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Thyrogen (when available) Binding of thyrotropin alfa to TSH receptors on normal thyroid epithelial cells or on well-differentiated thyroid cancer tissue stimulates iodine uptake and organification. Thyrogen is an exogenous source of human TSH that offers an additional diagnostic tool in the follow-up of patients with a history of well-differentiated thyroid cancer. For detection of residueal or recurrent thyroid cancer Mechanism Of Action: Binds to the thyrotropin receptors found on any residual thyroid cells or tissues. This stimulates radioactive iodine uptake for better radiodiagnostic imaging. News Articles on Thyrotropin Alfa Genzyme shifting work from Allston plant - Jan 4, 2010 Genzyme distributes Cerezyme, Fabrazyme, Myozyme, and Thyrogen out of its Allston plant; it manufactures Myozyme (used to treat Pompe disease) and Thyrogen ... Boston Globe Anti-smoking drugs in health basket - Dec 23, 2009 Nexavar, Temodal, Torisel, Gemzar, Glivec, Mozobil, Vigam, Thyrogen and Revlimid for cancer; Intelence for AIDS; Mimpara and Aclasta for endocrinology; ... Jerusalem Post National business briefs - 14 Nov 2009 The drugs, which are used to treat rare enzyme disorders, include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. The FDA estimates the ... NewsOK.com Some genetic drugs impure - Nov 13, 2009 Medicines affected include Cerezyme, Genzyme's biggest selling product, as well as Fabrazyme, Myozyme, Aldurazyme and Thyrogen. The contaminated drugs were ... Chicago Tribune Genzyme Corporation - SWOT Analysis - New Report Published - Nov 12, 2009 Renagel (sevelamer hydrochloride), Hectorol (doxercalciferol), Thyrogen (thyrotropin alfa for injection) and hematologic oncology products. ... OfficialWire (press release) Genzyme Products[Cerezyme, Fabrayzme, Myozyme, Aldurazyme, Thyrogen]: Foreign ... - Nov 13, 2009 Cerezyme, Fabrazyme, Myozyme, and Thyrogen are supplied as lyophilized powders requiring reconstitution before administration; Aldurazyme is supplied as a ... PharmaLive (press release) (subscription) Thyroid News from the Journal of Clinical Endocrinology and Metabolism - Nov 5, 2009 After thyroid cancer, thyroid patients who have had withdrawal of levothyroxine -- versus use of recombinant TSH (Thyrogen) -- have similar rates of tumor ... About - News & Issues (blog) UPDATE 1-U.S. FDA: Some Genzyme drugs contaminated - Nov 13, 2009 Myozyme for Pompe disease, Aldurazyme for Mucoploysaccharidosis Type I, and Thyrogen, which is used in the diagnosis and treatment of thyroid cancer. ... 路透中国 PBS listings in effect - Nov 2, 2009 In another change, prescribers will no longer have to gain preapproval to prescribe for the thydroid cancer treatment Thyrogen (Thyrotropin alfa). ... Pharmacy News Genzyme Issues Letters to U.S. Healthcare Providers - Nov 13, 2009 Aldurazyme (R) (laronidase), as well as Thyrogen (R) (thyrotropin alfa for injection), filled at its Allston Landing manufacturing facility. ... RTT News (press release) FDA Said Pieces Of Steel, Rubber, Fiber Found In Drugs Made By Genzyme (GENZ) - Nov 13, 2009 The drugs include Cerezyme, Fabrazyme, Myozyme, Aldurazyme, and Thyrogen. The FDA estimated that contamination only affected about 1% of the company's ... FOXBusiness FDA finds bits of steel, rubber in Genzyme drugs - Nov 13, 2009 The drugs, which are used to treat rare enzyme disorders, include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. The FDA estimates the ... NECN US stocks advance - Nov 13, 2009 US regulators said some lots of the company's Cerezyme, Fabrazyme, Myozyme, Aldurazyme, and Thyrogen may be contaminated with stainless steel fragments, ... The Age Steel, rubber found in some Genzyme drugs - Nov 13, 2009 Other Genzyme products included in the letter are Aldurazyme, for a life-threatening disease known as MPS 1, and Thyrogen, which is used in the treatment of ... Forbes FDA finds bits of steel, rubber in Genzyme drugs - Nov 13, 2009 The drugs affected by the latest announcement include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. All are manufactured at a biotech plant in ... The Associated Press Foreign Particles Found In Some Genzyme Medicines - Nov 13, 2009 ...adverse effects associated with the products, which include Genzyme's top sellers Cerezyme and Fabrazyme, as well as Myozyme, Aldurazyme and Thyrogen. ... Capital.gr (press release) Genzyme Releases 3Q Financial Results - Oct 26, 2009 Genzyme also markets Thymoglobulin and Thyrogen in the country, has a commercial office in New Delhi, and is engaged in clinical development work. Trading Markets (press release) Genzyme Reports Third-Quarter Financial Results - Oct 22, 2009 Sales of Thyrogen ® (thyrotropin alfa for injection) were $41.7 million compared with $38.2 million during the third quarter of 2008. ... Business Wire (press release) חדשות טובות עבור פרוטליקס? חשש ×›×™ תרופות של חברת ×’'× ×–×™×™×? זוהמו במתכת וגומי - Nov 13, 2009 ...התרופות, בהן כמה ×ž×”× ×ž×›×¨×•×ª ביותר של החברה, שקיי×? חשש לזיהו×? בחלקן הן: Cerezyme, Fabrazyme, Myozyme, Aldurazyme ו-Thyrogen. "זיהומי×? ×?לה עלולי×? לגרו×? ל×?ירועי×? ... The Marker Genzyme Q3 Profit Falls 87%; Cuts FY09 Earnings Outlook - Update - Oct 21, 2009 Sales of Thyrogen totaled $41.7 million, up from $38.2 million during the prior-year period. Genzyme's Hematologic Oncology segment revenues more than ... Trading Markets (press release) … Announces European Marketing Approval of Thyrogen for Use in... - Mar 3, 2005 CAMBRIDGE, Mass., March 3 /PRNewswire-FirstCall/ -- Genzyme Corporation announced today that the European Commission has approved the company's marketing ... RedOrbit Genzyme Announces FDA Approval of Thyrogen(R) for Use in - Dec 17, 2007 CAMBRIDGE, Mass., Dec. 17 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ) announced today that the US Food and Drug Administration (FDA) has approved ... Bloomberg Genzyme Announces FDA Approval of Thyrogen® For Use In Thyroid … - Dec 18, 2007 Genzyme Corp. (Nasdaq: GENZ) announced today that the US Food and Drug Administration (FDA) has approved a supplemental indication for Thyrogen® ... webwire.com Genzyme Granted Label Change for Thyrogen. - Feb 1, 2006 CAMBRIDGE, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Genzyme Corp. today announced that the US Food and Drug Administration (FDA) has authorized a label ... Free with registration - PR Newswire - AccessMyLibrary.com … Granted Label Change for Thyrogen. - PR Newswire | HighBeam … - Feb 1, 2006 Genzyme Granted Label Change for Thyrogen. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Announces European Marketing Approval of Thyrogen for Use in... - Mar 3, 2005 Genzyme Announces European Marketing Approval of Thyrogen for Use in Thyroid Cancer Ablation. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Release: Genzyme Announces FDA Approval of Thyrogen(R) for Use in ... - Dec 17, 2007 Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research PharmaCare Included in Genzyme's Thyrogen(R) Distribution Network - Apr 21, 2005 LINCOLN, RI, April 21 /PRNewswire-FirstCall/ -- PharmaCare, a subsidiary of CVS Corporation , announced today that its specialty pharmacy division, ... RedOrbit Genzyme gets label change for Thyrogen.(Brief Article) - Feb 6, 2006 US biotechnology firm Genzyme says that the Food and Drug Administration has authorized a label modification for Thyrogen (thyrotropin alfa for injection) ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Thyrogen.(NEW INDICATIONS)(Brief article) - Jan 28, 2008 Genzyme's Thyrogen (thyrotropin alfa for injection), (617) 252-7500, ... Thyrogen was originally approved in 1998 for use as a diagnostic tool for patients ... Free with registration - Drug Topics - AccessMyLibrary.com … gets European marketing approval of Thyrogen for thyroid tissue... - Apr 3, 2005 ..."We believe that the use of Thyrogen in remnant ablation procedures can ... Thyrogen is an important adjunct to thyroid cancer management because it can ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones Thyrogen. - Jan 28, 2008 Genzyme's Thyrogen (thyrotropin alfa for injection), (617) 252-7500, ... Thyrogen was originally approved in 1998 for use as a diagnostic tool for patients ... $9.94 - Drug Topics - Alacra Store … gets European marketing approval of Thyrogen for thyroid tissue... - Mar 29, 2005 ..."We believe that the use of Thyrogen in remnant ablation procedures can ... Thyrogen is an important adjunct to thyroid cancer management because it can ... Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones Article: Thyrogen.(NEW & APPROVED) - Internal Medicine News | … - Jan 15, 2008 Thyrogen.(NEW & APPROVED) ... find Internal Medicine News articles. Thyrogen (thyrotropin alfa for injection, Genzyme Corp.) A recombinant form of human t. Pay-Per-View - Internal Medicine News - HighBeam Research … gets European marketing approval of Thyrogen for thyroid tissue... - Mar 28, 2005 ..."We believe that the use of Thyrogen in remnant ablation procedures can ... Thyrogen is an important adjunct to thyroid cancer management because it can ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones International Device Approvals: Total Facet, Thyrogen, EnRhythm, … - Mar 15, 2005 March 15, 2005 — The European Commission has approved for use in the European Union an arthroplasty system for the treatment of spinal stenosis; ... Medscape Thyroid-cancer test reveals recurrence early - Jun 24, 2005 Thyrogen, approved for use in 1998, allowed people to have a stimulated Tg test and continue taking the synthetic hormone. The present study sought to help ... Medical News Today - Medical News Today (press release) … : PharmaCare Included in Genzyme's Thyrogen(R) Distribution... - Apr 21, 2005 PharmaCare Included in Genzyme's Thyrogen(R) Distribution Network. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … new use for Genzyme's Thyrogen.(Pharmaceutical industry)(European ... - Mar 14, 2005 USA-based Genzyme says that the European Commission has approved its Marketing Authorization Application for a therapeutic indication for Thyrogen ... $4.95 - Pharma Marketletter - ECNext Genzyme Gets EU Approval of Thyrogen for Use in Thyroid Cancer … - Mar 7, 2005 Genzyme has announced that the European Commission has approved the company's marketing application for a therapeutic indication for Thyrogen when used in ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones Thyrogen registered in Europe. - Apr 25, 2005 The European Commission has approved Genzyme's Thyrogen (thyrotropin alpha) as a post-surgery treatment for patients with thyroid cancer. ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Thyrogen, nueva terapia para el cáncer de tiroides. - Dec 31, 2006 Una innovadora terapia viene a marcar un importante avance en el tratamiento y control del cáncer de tiroides, ya que evita el hipotiroidismo y sus sÃntomas ... Free with registration - Siempre! - AccessMyLibrary.com … разрешило применение препарата Thyrogen длÑ? аблации тканей Щ? - Dec 19, 2007 Ð?мериканÑ?каÑ? компаниÑ? Genzyme Corp. получила разрешение УправлениÑ? по контролю за продовольÑ?твием и медикаментами СШÐ? (ФДÐ?) на раÑ?ширение показаний к ... ФармацевтичеÑ?кий веÑ?тник Hormonpräparat Thyrogen verbessert Schilddrüsenkrebs-Therapie - Jun 30, 2006 Chirurgen und Nuklearmediziner der Medizinischen Hochschule Hannover haben eine neue Therapie zur Behandlung von Schilddrüsenkrebs entwickelt. ... journalmed.de Thyroid Cancer Test Reveals Recurrence Early - Jul 14, 2005 Thyrogen, approved for use in 1998, allowed people to have a stimulated Tg test and continue taking the synthetic hormone. The present study sought to help ... emaxhealth.com JPMorgan to hire former Washington Mutual staff - Dec 18, 2007 The new approval means Thyrogen can be used in combination with radiation. Cambridge-based Genzyme's shares fell $1.34 to $73.53. (Bloomberg) ... Boston Globe Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue - Jan 9, 2006 Sales of Thyrogen® (thyrotropin alfa for injection) increased 18 percent to $21 ... For the year, Thyrogen sales were $78 million, an increase of 23 percent ... webwire.com Thyroid-cancer Test Reveals Recurrence Early - Jul 1, 2005 Thyrogen, approved for use in 1998, allowed people to have a stimulated Tg test and continue taking the synthetic hormone. The present study sought to help ... sciencedaily.com Mass., Maine, NStar oppose energy agreement - Feb 2, 2006 Thyrogen is approved by the FDA as a diagnostic tool used to manage patients being tested for thyroid cancer, allowing patients to avoid potentially ... Boston Globe Bisturi più «leggero» per la tiroide - Feb 21, 2006 Ma ora l'estensione delle indicazioni dà il via libera al Thyrogen anche in campo ... La somministrazione di Thyrogen rende superflua l'interruzione della ... Corriere della Sera Vida - El Universal - Columnas - Jan 16, 2007 Los especialistas dicen que mediante la estimulación con thyrogen, ... Antes del thyrogen, señala Sánchez Arriaga, la revisión de control requerÃa que los ... El Universal - El Universal (México) A blood test for thyroid cancer can detect persistent or recurrent... - Jun 27, 2005 Thyrogen, approved for use in 1998, allowed people to have a stimulated Tg test and continue taking the synthetic hormone. The present study sought to help ... News-Medical.net Press Release: Biogen Idec to present at Merrill Lynch Global … - Feb 2, 2006 Biogen Idec to present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference and Genzyme granted label change for Thyrogen. Pay-Per-View - M2 Presswire - HighBeam Research Thyroid-cancer test reveals recurrence early - Jun 23, 2005 Thyrogen, approved for use in 1998, allowed people to have a stimulated Tg test and continue taking the synthetic hormone. The present study sought to help ... PsychCentral.com Thyroid Cancer Test Reveals Recurrence Early - Jul 30, 2005 Thyrogen, approved for use in 1998, allowed people to have a stimulated Tg test and continue taking the synthetic hormone. The present study sought to help ... emaxhealth.com Genzyme Corporation Reports Strong Growth in Second Quarter 2008 - Jul 24, 2008 Sales of Thyrogen® (thyrotropin alfa for injection) remained strong, increasing 34 ... The use of Thyrogen in ablation procedures is contributing to the ... allamericanpatriots.com MHH verbessert Therapie bei Schilddrüsenkrebs - Jun 29, 2006 ..."Dank des künstlich erzeugten Hormons Thyrogen, das die Schilddrüse stimuliert, ... aus Berlin, dem noch ohne die neue Thyrogen-Therapie die Schilddrüse ... innovations report El cáncer de tiroides - Mar 10, 2007 Los especialistas dicen que mediante la estimulación con thyrogen, ... Antes del thyrogen, señala Sánchez Arriaga, la revisión de control requerÃa que los ... El Siglo de Torreón Genzyme Reports Strong Fourth-Quarter Revenue Growth to Conclude … - Jan 9, 2007 Sales of Thyrogen® (thryotropin alfa for injection) increased 18 percent in the ... For the year, Thyrogen sales rose 21 percent to $94 million from $78 ... webwire.com Bisturi più «leggero» per la tiroide - Sep 27, 2005 Ma ora l'estensione delle indicazioni dà il via libera al Thyrogen anche in campo ... La somministrazione di Thyrogen rende superflua l'interruzione della ... Corriere della Sera FDA finds steel, rubber, other substances in Genzyme biotech drugs, … - May 28, 2008 The drugs affected by the latest announcement include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen. All are manufactured at a biotech plant in ... Los Angeles Times Genzyme Reports Second-Quarter GAAP EPS of $0.46, Non-GAAP EPS … - Jul 14, 2005 Sales of Thyrogen(R) (thyrotropin alfa for injection) were $20.7 million in the quarter, up 27 percent from $16.3 million in the second quarter a year ago. ... $4.95 - PR Newswire - ECNext Genzyme Reports Growth in First Quarter. - Apr 25, 2007 Also within the Therapeutics area, sales of Thyrogen (thyrotropin alfa for injection) ... Thyrogen is currently indicated for use in diagnostic procedures ... $4.95 - M2 Presswire - ECNext Press Release: DRAXIS Receives FDA Approval for Diagnostic Iodine I- … - Jan 13, 2006 Article: Genzyme Announces European Marketing Approval of Thyrogen for Use ... ... Thyrogen is an important adjunct to thyroid cancer management because it ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: FDA Grants Fast Track Designation for the Investigation... - Feb 2, 2006 Article: Genzyme Announces FDA Approval of Thyrogen(R) for Use in ... ... Article: Genzyme Announces European Marketing Approval of Thyrogen for Use ... ... Pay-Per-View - PR Newswire - HighBeam Research Epocrates Rx for iPhone - Aug 15, 2008 As good as it is, Epocrates Rx isn't perfect: for example, I couldn't find Thyrogen in its database, nor are iodinated contrast media or other diagnostic ... NetworkWorld.com Genzyme Expands its Research and Manufacturing Presence in … - Oct 5, 2005 Genzyme also performs the filling and finishing for Thyrogen® ... Thyrogen is a diagnostic used in the screening of patients who have had thyroid cancer. ... webwire.com Biogen Idec to present at Merrill Lynch Global Pharmaceutical, … - Feb 2, 2006 ...(Nasdaq: GENZ) recently announced that the US Food and Drug Administration (FDA) has authorized a label modification for Thyrogen (thyrotropin alfa for ... $4.95 - M2 Presswire - ECNext Genzyme Delivers Earnings Beat - Oct 24, 2007 Genzyme also reported a 20% increase in the sale of Thyrogen, an injection used by thyroid cancer patients while they are off hormones for periods of ... TheStreet.com - TheStreet.com (subscription) Genzyme's 2004: Strong Sales, Growth Provided 'Stellar' Year - Jan 13, 2005 Genzyme's thyroid cancer diagnostic, Thyrogen, had sales of $18 million in the fourth quarter and $63 million for the year. Combined sales of the organ ... BioWorld Online - BioWorld Online Serum Thyrotropin (TSH) Levels after Recombinant Human TSH … - Sep 20, 2005 Patients pretreated with rhTSH (Thyrogen, Genzyme Corp.) received 0.9 mg, im, into the gluteus maximus on 2 consecutive days according to the standard adult ... Journal of Clinical Endocrinology and... Genzyme Beats Estimates, Raises Outlook - Jul 25, 2007 ...or Hurler Syndrome, therapy Aldurazyme rose 24% to $29.1 million; and injectable thyroid cancer treatment Thyrogen sales grew 25% to $29.5 million. ... TheStreet.com - TheStreet.com (subscription) Genzyme Delivers Strong Third-Quarter Results. - Oct 18, 2005 Sales of Thyrogen(R) (thyrotropin alfa for injection) increased 20 percent to $18.5 million in the third quarter from $15.4 million a year earlier. ... $4.95 - PR Newswire - ECNext Genzyme Delivers Excellent Fourth-Quarter and 2004 Performance ------... - Feb 17, 2005 Sales of Thyrogen(R) (thyrotropin alfa for injection) are expected to reach ... Thyrogen is indicated for use as a diagnostic tool in the management of ... $4.95 - PR Newswire - ECNext University Hospital To Halt 3 Cancer Therapies - Oct 15, 2008 Thirty-seven patients affected are being notified when they come in for Thyrogen injections, chemotherapy and Procrit therapy. ... Pay-Per-View - Tampa Tribune - ProQuest Archiver Press Release: FDA Grants AstraZeneca Orphan-Drug Designation for … - Oct 31, 2005 Article: Genzyme Announces FDA Approval of Thyrogen(R) for Use in ... ... Article: Genzyme Announces European Marketing Approval of Thyrogen for Use ... ... Pay-Per-View - PR Newswire - HighBeam Research PharmaCare helps get the most out of drug spending. - Aug 29, 2005 Genzyme's designation of PharmaCare as one of a select group of providers "ensures both patients and physicians will have their Thyrogen prescription needs ... $9.94 - Chain Drug Review - Alacra Store Genzyme guidance upped on good 2nd qtr.(Brief Article) - Jul 25, 2005 Sales of Thyrogen (thyrotropin alfa for injection) were $20.7 million in the quarter, up 27%. Genzyme anticipates US action this quarter on its application ... $4.95 - Pharma Marketletter - ECNext Genzyme Corporation Analyst Meeting - Final. - May 6, 2005 In the Oncology area, while we had Thyrogen, Thyrogen was fairly new and had ... Renagel, Synvisc, Campath, Thyrogen and Thymoglobulin all in what I would ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Genzyme to begin $150m expansion of Allston plant - Sep 15, 2007 The plant is also used to package two other products, Aldurazyme, which treats MPS I disease, a genetic disorder; and Thyrogen, a thyroid cancer drug. ... Boston Globe Genzyme's Revenue Set to Climb - Jan 9, 2006 Sales of the thyroid drug Thyrogen were up 18% to $21 million. Genzyme issued initial projections of $3.1 billion to $3.3 billion in revenue and earnings of ... TheStreet.com - TheStreet.com (subscription) MPE e Saúde firmam acordo para fornecimento de remédio para … - May 20, 2008 ...para assegurar o fornecimento do medicamento Thyrogen tirotrofina alfa - TSH Recombinante), custo unitário de R$ 7 mil, aos pacientes sumetidos a ... Correio do Estado Recombinant Human Thyrotropin Enhances Endothelial-Mediated … - Dec 23, 2008 On the mornings of d 1 and 2, the patients received an im injection of rhTSH (Thyrogen; Genzyme, Cambridge, MA) at a dose of 0.9 mg. ... Journal of Clinical Endocrinology and... Genzyme's 4th-qtr sales climb 21%, beating forecasts; predicts EPS of... - Jan 21, 2008 In addition, Genzyme's thyroid cancer differentiation agent Thyrogen (thyotropin alfa for injection) achieved turnover of $31.0 million, ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Challenges in Developing Therapies for Rare Diseases Including … - Jun 9, 2005 Aldurazyme (for Mucopolysaccharidosis I), and Thyrogen (for thyroid cancer). Other companies including Transkaryotic Therapies (Cambridge, MA), ... Nature.com Epocrates ships pharmacy app for iPhone - Aug 18, 2008 As good as it is, Epocrates Rx isn't perfect: for example, I couldn't find Thyrogen in its database, nor are iodinated contrast media or other diagnostic ... ITWorld Canada Illness isn't part of the game - May 29, 2005 Instead of receiving just two injections of Thyrogen to see if she has beaten the disease, Johnson faces a six- to seven-week process. ... Las Vegas Review-Journal - Las Vegas Review-Journal Event Brief of Q2 2007 Genzyme Corporation Earnings Conference Call -... - Jul 25, 2007 All the other major business areas, including Synvisc, Oncology, Transplant, Sepra, and Thyrogen, increased on qtr-to-qtr basis, as well as on an YtoY basis ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Issues Updates on Genzyme Corp. - Jul 12, 2006 Sales of Thyrogen (thyrotropin alfa for injection) rose to $23.7 million in the second quarter, a 15 percent increase from sales of $20.7 million during the ... Free with registration - M2 Presswire - AccessMyLibrary.com Competitors by Product Report - Jul 19, 2008 Acid Sphingomyelinase Enzyme Replacement Therapy; Gene Therapy; GENZ-112638; Genz-642347; Thymoglobulin (Anti-Thymocyte Globulin); Thyrogen (Thyrotropin ... $75.00 - Revere - Alacra Store ALSO NOTED: Galvus gets EU committee nod; Merck appoints Vanderbilt … - Dec 17, 2007 Genzyme said the FDA has broadened the use of its thyroid cancer diagnostic tool Thyrogen to include identification of cancerous residue in patients who ... FiercePharma Event Brief of Q1 2006 Genzyme Corporation Earnings Conference Call -... - Apr 19, 2006 Thyrogen revenue came in pretty strong, posting a 30% increase over 1Q05 and came in about $23m. 9. Oncology was $12m. 10. The negative impact of FX on the ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Competitors by Product Report - Dec 6, 2008 Acid Sphingomyelinase Enzyme Replacement Therapy; Gene Therapy; GENZ-112638; Genz-642347; Thymoglobulin (Anti-Thymocyte Globulin); Thyrogen (Thyrotropin ... $75.00 - Revere Reports - Revere August 2007 PBS Listings, Australia - Aug 3, 2007 Thyroid cancer treatment after the surgical removal of the thyroid will be improved by THYROGEN® (thyrotropin). This is to be listed at a cost of about $4.4 ... Medical News Today - Medical News Today (press release) Genzyme launches late-stage tests of anti-diarrhea drug - Apr 4, 2005 Genzyme in March gained European marketing approval for expanded use of Thyrogen to be used in combination with a treatment for thyroid cancer. ... Boston Business Journal Event Brief of Q1 2006 Genzyme Corporation Earnings Conference Call -... - Apr 19, 2006 Thyrogen revenue came in pretty strong, posting a 30% increase. over 1Q05 and came in about $23m. 9. Oncology was $12m. 10. The negative impact of FX on the ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Genzyme inaugurates Middle East office in Dubai - Nov 11, 2006 ...transplant patients, and Thyrogen, an adjunct to thyroid cancer disease management designed to aid in the treatment and earlier detection of recurrence. ... AME - AME New tools offer help in fighting thyroid Ca.(Endocrinology) - Feb 1, 2005 Furio Pacini, MD, was a coinvestigator in a multinational randomized 63-patient open-label trial comparing rTSH (Thyrogen) and thyroid hormone withdrawal as ... Free with registration - Internal Medicine News - AccessMyLibrary.com Recombinant hTSH in the Diagnosis of Congenital Hypothyroidism - Jan 26, 2007 Interventions: Patients received im 0.6 mg/m 2 rhTSH (Thyrogen, Genzyme) on two consecutive days. Results: rhTSH pharmacokinetics, Cmax, t1/2 and AUC in ... Journal of Clinical Endocrinology and... Limited Value of Repeat Recombinant Human Thyrotropin (rhTSH)- … - Oct 30, 2007 Briefly, patients received one injection of rhTSH (0.9 mg im, Thyrogen; Genzyme Therapeutics, Cambrige, MA) for two consecutive days. Serum samples for TSH, ... Journal of Clinical Endocrinology and... Optioning Your Drugs - Sep 1, 2006 One of the drugs, Thyrogen, was approved in 1998 for treating thyroid cancer; in 2005 the drug brought in $78 million in sales for Genzyme. ... Scientist Breaking Ground on Allston Plant Expansion, Genzyme Eyes 2008 FDA … - Sep 24, 2007 ...to combat complex carbohydrates called glycosaminoglycans; and Thyrogen, used via injection in the screening of patients who have had thyroid cancer. ... genomeweb.com The use of recombinant human thyrotropin produced by Chinese hamster ... - Feb 1, 2006 Recombinant human TSH (rec-hTSH; Thyrogen, lot M-17073) obtained from transformed Chinese hamster ovary cells was tested for both radioiodination and ... Journal of Clinical Endocrinology and... Fosrenol's Threat To Renagel May Be Leveling Off: Report - Apr 18, 2005 And of course for Genzyme there's the well-known marketed lineup - flagships Ceredase/Cerezyme, plus Renagel, Synvisc, Campath, Thyrogen, Thymoglobulin, ... BioWorld Online - BioWorld Online Rh-TSH Effective in Tissue Ablation to Prevent Thyroid Cancer - Jun 14, 2007 Thyrotropin alfa for injection/rh-TSh ( Thyrogen, Genzyme) was approved in 1998 by the US Food and Drug Administration for use in radioiodine scans to ... Medscape Event Brief of Q3 2006 Genzyme Corporation Earnings Conference Call -... - Oct 1, 2006 Cerezyme, Fabrazyme, Aldurazyme, Thymoglobulin, the Sepra products, Thyrogen, all produced pretty much the growth rates and results that GENZ [hasn't] seen ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com TransMolecular Expands Management Team - Nov 30, 2005 Carticel(R) and Thyrogen(R). She also was the regulatory lead for Genzyme collaborations with Diacrin, Inc., Cambridge Antibody Technologies, Dyax, ... RedOrbit Genzyme Begins $150 Million Expansion of Boston Manufacturing Facility - Sep 19, 2007 Genzyme also performs the filling and packaging for two products manufactured at other sites: Aldurazyme(R) (laronidase) for MPS I disease and Thyrogen(R) ... Boston/SF Researchers use blood tests to detect cancer - Jul 19, 2005 Thyrogen, a new drug, tests and measures amounts of thyroglobulin in the body when injected into the body and does not allow for negative side effects ... OSU - The Lantern Leading biotech company to host fieldbus seminar - Sep 23, 2005 Commercial products currently produced at Allston Landing include: Cerezyme, Fabrazyme, Thyrogen and Aldurazyme. Catherine Cook, Genzyme¹s director of ... CONTROL Magazine Recombinant Human Thyrotropin for the Diagnosis and Treatment of a … - Mar 1, 2005 Because iodine uptake by most thyroid carcinomas is quite low in the absence of high levels of ambient TSH, we used recombinant human TSH (rhTSH) (Thyrogen) ... Journal of Clinical Endocrinology and... Genzyme's 2nd qtr profit hit by license cost. - Aug 4, 2008 Sales of Thyrogen (thyrotropin alfa for injection) grew 34% to $39.4 million. Within Genzyme's renal business, sevelamer therapies Renagel (sevelamer HCl) ... $9.94 - Pharma Marketletter - Alacra Store Top 50 packagers: pharmaceutical.(TOP 200 PACKAGERS)(Company … - Jul 1, 2007 Thyrogen; Cerezyme 33 Herbalife Ltd. Lifeoff; Niteworks; 3 Georgetown, Grand Herbalife; Garden 7 Cayman / Los Angeles, Calif. 34 Perrigo Co. ... Free with registration - Food & Drug Packaging - AccessMyLibrary.com Thyroid mimetics promising for lipid lowering.(Endocrinology) |... - Dec 1, 2008 Patients find this extremely ... trial comparing rTSH (Thyrogen) and thyroid hormone withdrawal as preparation for remnant ... ... Pay-Per-View - Internal Medicine News - HighBeam Research Genzyme Reports Strong Third-Quarter Financial Results. - Oct 12, 2006 Sales of Thyrogen(R) (thyrotropin alfa for injection) rose to $22.4 million in the second quarter, a 21 percent increase from sales of $18.5 million during ... $4.95 - PR Newswire - ECNext Competitors by Product Report - Oct 4, 2008 Acid Sphingomyelinase Enzyme Replacement Therapy; Gene Therapy; GENZ-112638; Genz-642347; Thymoglobulin (Anti-Thymocyte Globulin); Thyrogen (Thyrotropin ... $75.00 - Revere Reports - Revere Genyzyme's 3rd-qtr results beat forecasts with an 18% increase in... - Oct 24, 2005 Sales of Thyrogen (thyrotropin alfa for injection) increased 20% to $18.5 million. Within the transplant area, Genzyme notes that combined sales of ... $4.95 - Pharma Marketletter - ECNext Genzyme's 1st-qtr revenues up 28%.(Brief Article) - May 2, 2005 ...patients with MPS 1, reached $15.9 million versus $7.4 million in the first quarter of 2004. Thyrogen (thyrotropin alfa) revenues rose 27% to $14.0 million. $4.95 - Pharma Marketletter - ECNext Competitors by Product Report - Apr 14, 2007 Acid Sphingomyelinase Enzyme Replacement Therapy; Gene Therapy; GENZ-112638; Thymoglobulin (Anti-Thymocyte Globulin); Thyrogen (Thyrotropin Alfa) ... $75.00 - Revere Reports - Revere LEEM's 2005 review of French clinical innovation finds 46 notable … - Mar 6, 2006 US specialist drugmaker Genzyme's Thyrogen (thyrotropin alfa for injection) optimizes treatment and surveillance of thyroid cancer. ... $4.95 - Pharma Marketletter - ECNext Brand Names/Synonyms: Thyrogen is also known by the following brand names and/or synonymsFollitropin beta chain precursor;Follicle-stimulating hormone beta subunit;FSH-beta;FSH-B; Thyrogen (Genzyme Inc) Drug Category: Thyrogen is categorized under the following by the FDA: Diagnostic Agents; thyroid function (36:60.00) Dosage Forms: POWDER FOR SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Human alpha thyrotropin |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |